Literature DB >> 24293121

Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Leo Ungar1, Andre Altmann, Michael D Greicius.   

Abstract

Alzheimer's disease (AD) is an increasingly prevalent, fatal neurodegenerative disease that has proven resistant, thus far, to all attempts to prevent it, forestall it, or slow its progression. The ε4 allele of the Apolipoprotein E gene (APOE4) is a potent genetic risk factor for sporadic and late-onset familial AD. While the link between APOE4 and AD is strong, many expected effects, like increasing the risk of conversion from MCI to AD, have not been widely replicable. One critical, and commonly overlooked, feature of the APOE4 link to AD is that several lines of evidence suggest it is far more pronounced in women than in men. Here we review previous literature on the APOE4 by gender interaction with a particular focus on imaging-related studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24293121      PMCID: PMC4282773          DOI: 10.1007/s11682-013-9272-x

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  134 in total

1.  Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.

Authors:  May A Beydoun; Adel Boueiz; Marwan S Abougergi; Melissa H Kitner-Triolo; Hind A Beydoun; Susan M Resnick; Richard O'Brien; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

2.  Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve.

Authors:  Larry A Tupler; K Ranga R Krishnan; Daniel L Greenberg; Santica M Marcovina; Martha E Payne; James R MacFall; H Cecil Charles; P Murali Doraiswamy
Journal:  Neurobiol Aging       Date:  2006-08-17       Impact factor: 4.673

3.  The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.

Authors:  Y Stern; J Brandt; M Albert; D M Jacobs; X Liu; K Bell; K Marder; M Sano; S Albert; C Del-Castillo Castenada; F Bylsma; B Tycko; R Mayeux
Journal:  Ann Neurol       Date:  1997-05       Impact factor: 10.422

4.  Differential effects of the APOE genotype on brain function across the lifespan.

Authors:  N Filippini; K P Ebmeier; B J MacIntosh; A J Trachtenberg; G B Frisoni; G K Wilcock; C F Beckmann; S M Smith; P M Matthews; C E Mackay
Journal:  Neuroimage       Date:  2010-08-10       Impact factor: 6.556

Review 5.  Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.

Authors:  Eric M Reiman; Jessica B S Langbaum; Adam S Fleisher; Richard J Caselli; Kewei Chen; Napatkamon Ayutyanont; Yakeel T Quiroz; Kenneth S Kosik; Francisco Lopera; Pierre N Tariot
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

6.  Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader; R E Tanzi
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

7.  The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism.

Authors:  Elizabeth H Corder; Estifanos Ghebremedhin; Miles G Taylor; Dietmar R Thal; Thomas G Ohm; Heiko Braak
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

8.  A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment.

Authors:  M C Tierney; J P Szalai; W G Snow; R H Fisher; T Tsuda; H Chi; D R McLachlan; P H St George-Hyslop
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

9.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

View more
  68 in total

Review 1.  Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause.

Authors:  Kelly N Morgan; Carol A Derby; Carey E Gleason
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Authors:  Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

3.  APOE ε4 allele modifies the association of lead exposure with age-related cognitive decline in older individuals.

Authors:  Diddier Prada; Elena Colicino; Melinda C Power; Marc G Weisskopf; Jia Zhong; Lifang Hou; Avron Spiro; Pantel Vokonas; Kasey Brenan; Luis A Herrera; Joel Schwartz; Robert Wright; Howard Hu; Andrea A Baccarelli
Journal:  Environ Res       Date:  2016-07-27       Impact factor: 6.498

Review 4.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

5.  Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.

Authors:  Shanna L Burke; Tianyan Hu; Christine E Spadola; Tan Li; Mitra Naseh; Aaron Burgess; Tamara Cadet
Journal:  Sleep Med       Date:  2018-09-20       Impact factor: 3.492

Review 6.  The Role of Sex and Sex Hormones in Neurodegenerative Diseases.

Authors:  Elisabetta Vegeto; Alessandro Villa; Sara Della Torre; Valeria Crippa; Paola Rusmini; Riccardo Cristofani; Mariarita Galbiati; Adriana Maggi; Angelo Poletti
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

7.  Does Gender Influence the Relationship Between High Blood Pressure and Dementia? Highlighting Areas for Further Investigation.

Authors:  Anna E Blanken; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

8.  Attentional performance, impulsivity, and related neurotransmitter systems in apoE2, apoE3, and apoE4 female transgenic mice.

Authors:  Ingrid Reverte; Fiona Peris-Sampedro; Pia Basaure; Leticia Campa; Cristina Suñol; Margarita Moreno; José Luis Domingo; Maria Teresa Colomina
Journal:  Psychopharmacology (Berl)       Date:  2016-01       Impact factor: 4.530

9.  Memory-enhancing and brain protein expression-stimulating effects of novel calcium antagonist in Alzheimer's disease transgenic female mice.

Authors:  Baiba Jansone; Inga Kadish; Thomas van Groen; Ulrika Beitnere; Aiva Plotniece; Karlis Pajuste; Vija Klusa
Journal:  Pharmacol Res       Date:  2016-06-21       Impact factor: 7.658

10.  Impact of APOE-ε4 carriage on the onset and rates of neocortical Aβ-amyloid deposition.

Authors:  Samantha C Burnham; Simon M Laws; Charley A Budgeon; Vincent Doré; Tenielle Porter; Pierrick Bourgeat; Rachel F Buckley; Kevin Murray; Kathryn A Ellis; Berwin A Turlach; Olivier Salvado; David Ames; Ralph N Martins; Dorene Rentz; Colin L Masters; Christopher C Rowe; Victor L Villemagne
Journal:  Neurobiol Aging       Date:  2020-06-10       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.